AdjuCor
PrivateLast Round
Grant
Jun 9, 2022
Total Funding Raised
$38M
Company Overview
AdjuCor operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Grant round in June 2022.
AdjuCor is a medical device company that has developed a novel, patient-specific, extravascular, non-blood-contacting cardiac support technology for the treatment of advanced heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AdjuCor Comparables
Compare AdjuCor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FineHeart | 84% | |
| CorWave | 83% | |
| Evaheart, Inc. | 79% |
For institutional investors. Book with your work email.
AdjuCor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 9, 2022 | ||||
| Series B | Jun 9, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AdjuCor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2022
Secured $2.68M from the European Innovation Council Fund.
For institutional investors. Book with your work email.
AdjuCor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AdjuCor's valuation, stock price, and market status.
Is AdjuCor a public or private company?
AdjuCor is a private company.
What is the current stock price of AdjuCor?
AdjuCor is a private company, so its shares have no public market price. Caplight tracks AdjuCor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AdjuCor worth (valuation)?
Valuation information for AdjuCor is not publicly available.
Can I buy AdjuCor stock?
AdjuCor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AdjuCor's last funding round?
AdjuCor's most recent funding round was Grant on June 9, 2022.
Who are the main investors in AdjuCor?
Key investors in AdjuCor include European Innovation Council Fund.
Will AdjuCor IPO soon?
No public IPO plans have been announced for AdjuCor.
How can I track AdjuCor secondary market activity?
Caplight tracks bids, offers, and trades in AdjuCor's shares on secondary markets.